Ageing Research Reviews 'Under Review': What the Status Means

The first status period is not the full scientific review. It is the journal checking whether the record can be handled: files open correctly, author metadata is complete, disclosures are included, ethics statements are present, and the manuscript appears to match the journal's scope. For Ageing Research Reviews, this stage matters because a small administrative issue can look like a peer-review delay from the author's side. If the status changes quickly to Under Review, read that as a routing signal, not as proof that every reviewer has accepted.

The useful action during this stage is not to ask whether the editor likes the paper. It is to make sure every status email, submission-form field, and manuscript file points to the same claim. A mismatch between the cover letter, abstract, figure sequence, and supplementary files creates editorial friction even when the work is credible.

For Ageing Research Reviews, the file package should make clear that the manuscript reads as a critical review of ageing mechanisms, age-related disease, or lifespan biology rather than a broad narrative summary with limited synthesis before a reviewer has to reconstruct the claim.

At this point the manuscript is being read for fit. The editor is not only asking whether the manuscript is polished, but whether the manuscript reads as a critical review of ageing mechanisms, age-related disease, or lifespan biology rather than a broad narrative summary with limited synthesis. A manuscript can be technically careful and still difficult to route if the abstract promises one contribution while the methods, figures, data, or supplementary files support another.

The editor may be matching the manuscript to ageing biology editors, cellular-senescence reviewers, molecular-mechanism reviewers, neurodegeneration reviewers, cardiovascular and metabolic ageing reviewers, review-methodology readers, and Elsevier handling editors. That matching process can take time because the editor needs reviewers who can evaluate the central claim without rebuilding the manuscript's logic from scratch. Under Review can therefore cover both reviewer recruitment and active review.

At Ageing Research Reviews, the handling editor is usually making two decisions at once: whether the submission deserves outside assessment and which reviewer pool can test the manuscript fairly. The handling editor is usually testing scope, article type, evidence traceability, conflicts, reviewer availability, and whether the manuscript's strongest claim is auditable.

That editorial culture matters because the status label can look static while the handling editor checks the synthesis thesis, the literature-search boundary, and the disease-relevant mechanism map. Authors should prepare for comments on those components while the handling editor is still shaping the review path.

In parallel, the editor may be identifying two to three reviewers and checking whether the manuscript has the right scope for those reviewers. Recruiting reviewers can take 7 to 21 days when the topic sits between fields, depends on a specialized dataset, or requires both methodological and domain expertise. A Ageing Research Reviews manuscript can therefore show Under Review while the editor is still securing the right reviewer mix.

For authors, the useful question is not "has someone accepted yet?" The useful question is "if a reviewer accepts today, would the manuscript's the synthesis thesis, the literature-search boundary, and the disease-relevant mechanism map make the claim easy to evaluate?" That is the difference between passive waiting and productive waiting.

This is the main period in which reviewers evaluate the review. Because ARR publishes critical reviews rather than primary research, there is no results section to check.

Reviewers are testing whether the review has a real synthesis thesis rather than a narrative summary, whether the literature-search boundary is explicit, whether the mechanism coverage is current and tied to age-related disease relevance, and whether the figures resolve a controversy instead of decorating a reference list. The common weak point at ARR is a comprehensive summary that never takes a position or never explains why the review is needed now.

Active review is also where watching the portal tells you the least. A static status does not reveal whether one reviewer is late, whether the editor is waiting on a mechanism-versus-disease specialist, whether a reviewer declined, or whether reports are already in synthesis. The productive response is to prepare for the objection an ARR review most often draws.

Use the waiting window to build a response map around the synthesis: the likely objection (usually "what is the thesis, and why review this now?"), the section that answers it, the search boundary that supports it, and the controversy your figures resolve. If the decision is revise, that map saves time; if it is reject, it tells you whether the work belongs at a narrower or more clinical review venue.

After reports arrive, the editor turns them into a decision, which can still read as Under Review, Reviews Complete, or Decision in Process. Silence is not rejection: at ARR it often means the editor is reconciling a mechanism reviewer with a clinical or disease-relevance reviewer, or weighing whether the synthesis is novel enough to justify the review.

The synthesis window is where the editor reconciles those reads. If one reviewer wants broader coverage and another wants a sharper thesis, the decision letter takes longer because the editor has to decide which instruction governs the revision. That delay is procedural, not a verdict.

Not automatically. The usual explanation is reviewer recruitment or a late report, not a hidden rejection, and a critical review can be slow to place with reviewers who command the whole subfield. The useful read is whether elapsed time matches the stage: a quick move to Under Review then silence usually means one outstanding reviewer, while a later change usually means synthesis. Past 10 weeks with no movement, a polite inquiry is reasonable.

What you should not do is start re-writing in a panic or shop the review elsewhere. Use the time to sharpen the synthesis thesis and the "why now" argument before a revise, reject-with-comments, or redirect decision arrives.

Across our pre-submission review work with Ageing Research Reviews manuscripts, three named status-risk patterns explain most of the productive work authors can do while the portal still says Under Review. These patterns are useful because they are tied to manuscript components a reviewer can inspect, not to generic advice about waiting.

In our pre-submission review work on Ageing Research Reviews manuscripts, each pattern below becomes a concrete status-window task: pressure-test the synthesis thesis, the literature-search boundary, the disease-relevant mechanism map, and the "why now" argument before the reviewer report arrives.

The ARR submissions that generate the most avoidable anxiety are not the weak ones. They are well-read reviews whose authors wait passively instead of sharpening the thesis and the search boundary reviewers will press. ScienceDirect's guidance explains the workflow, but it does not warn that a comprehensive summary without a position is the most common way a credible review draws a major revision.

• Ageing Research Reviews evidence-chain gap: The editor needs to see the synthesis thesis, the literature-search boundary, and the disease-relevant mechanism map without piecing together the claim from scattered files. Prepare a one-page response map that ties the central claim to figures, methods, data files, theory, and limitations.

• Ageing Research Reviews reviewer-routing risk: The wrong reviewer pool can make a sound paper look less convincing than it is. Use the waiting window to identify how the abstract, keywords, suggested reviewers, article type, and field framing point to ageing biology editors, cellular-senescence reviewers, molecular-mechanism reviewers, neurodegeneration reviewers, cardiovascular and metabolic ageing reviewers, review-methodology readers, and Elsevier handling editors.

• Ageing Research Reviews source-to-claim friction: Reviewers move quickly from headline claim to evidence traceability. Check that source data, repository links, supplementary files, figure legends, models, theory logic, and methods are easy to audit.

• Ageing Research Reviews revision-readiness gap: Revision speed depends on whether authors already know which objection is likely. Draft answer blocks for the two most likely reviewer concerns before the decision letter arrives.

The recurring Manusights pattern is that authors over-prepare the wrong asset while the review is under review. At a review journal that usually means polishing prose when the likely objection is "this summarizes but does not synthesize," or expanding coverage when the real problem is an implicit search boundary. For Ageing Research Reviews, the highest-value waiting work is to make the synthesis thesis and the search boundary explicit enough that a reviewer can test the contribution without rebuilding it.

Across recent Manusights pre-submission reviews of ageing-biology reviews, the useful signal was not the portal label. It was whether the draft already stated its synthesis thesis and "why now" before reports arrived. That is why this page ties Under Review to the thesis, the search boundary, and the disease-relevant mechanism map an ARR review must defend, instead of only defining the status phrase.

If you want a second set of eyes before the report lands, use the Ageing Research Reviews AI review to identify reviewer-risk issues while the manuscript is still under review.

Trends in Molecular Medicine, Mechanisms of Ageing and Development, Experimental Gerontology, GeroScience, and disease-specialist review journals can be better fits when the manuscript is narrower, more clinical, or more mechanistic than the broad ARR readership. Do not treat transfer planning as pessimism. It is a way to shorten the next move if the decision letter confirms the current venue is one level too broad, too narrow, or too format-specific.

Source limitations: this page pairs ScienceDirect's public guidance with Manusights pre-submission-review experience on ageing-biology review manuscripts; it cannot see the private reviewer invitations, report status, or handling-editor notes inside your manuscript record.

The public pages can tell you the Editorial Manager portal, the article-scope language, the submission route, and the broad review policy. They cannot tell you whether your specific review has reviewers assigned, whether one is late, or whether the editor is leaning toward a revise or a redirect to a narrower venue. That is why this page separates official-source facts from interpretation: the ScienceDirect sources anchor the workflow; the Manusights layer is the synthesis-and-thesis risk read.

Official sources used for this Under Review interpretation:

• ScienceDirect journal page
• ScienceDirect author instructions
• Elsevier submission portal
• Elsevier author support page
• Elsevier author instructions

• Ageing Research Reviews hub
• Ageing Research Reviews submission guide
• Ageing Research Reviews metrics
• how to avoid desk rejection at Ageing Research Reviews
• journal-selection guide
• not-ready warning signs
• cover-letter guide

Before you wait another month, run a Ageing Research Reviews reviewer-risk check and prepare the revision map reviewers are most likely to force you to build later.

Source-specific notes from this research pass:

• ScienceDirect says Ageing Research Reviews publishes focused critical reviews on emerging findings in mechanisms of ageing and age-related disease.
• The guide identifies Review Article and Short Review formats and emphasizes cellular and molecular mechanisms, cancer, cardiovascular disease, diabetes, and neurodegenerative disorders.
• Elsevier support explains that Under Review can encompass several steps, so authors should not infer a decision from the label alone.